Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
N
290660
vs
K
KOSPI 200
Over the past 12 months, Neofect Co Ltd has underperformed KOSPI 200, delivering a return of -31% compared to KOSPI 200's +125% growth.
Stocks Performance
290660 vs KOSPI 200
Performance Gap
290660 vs KOSPI 200
Performance By Year
290660 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Neofect Co Ltd
Glance View
Neofect Co Ltd makes rehabilitation devices and software for people recovering from stroke, brain injury, and other conditions that limit movement. Its products combine sensors, games, and therapy tools to help patients practice arm, hand, and cognitive exercises in a more guided way than traditional equipment. The company sells to hospitals, rehab centers, clinics, and also to patients who use certain products at home. Its main products include connected rehab devices, digital therapy programs, and related software that tracks exercise performance and gives feedback to patients and therapists. Neofect usually earns money by selling the devices themselves and by charging for software, services, or contracts tied to therapy programs and clinical use. In plain terms, it sits between medical equipment and digital health: it makes the tools that help therapists deliver repeatable rehab exercises. What makes the business different is that it does not just sell a machine; it sells a rehab system built around measurement, feedback, and patient engagement. That matters because recovery often depends on doing the same exercises many times with the right form, and Neofect’s products are designed to make that easier to track and more engaging. This gives the company a role in modern rehabilitation where hospitals and therapists want tools that can support both in-clinic care and home practice.